Mariola Söhngen has joined Proteome Sciences Plc as a director and chief executive officer, taking over from the interim CEO Ian Pike who continues as chief scientific officer. Dr Söhngen was co-founder and former chief scientific officer of the German biotech Paion AG whose anaesthesia product received approval from the US Food and Drug Administration in July. She has also served as CEO at Mologen AG and Convert Pharmaceuticals SA and most recently, ran a pharmaceutical consultancy supporting Chinese companies and investors trying to enter the European pharma R&D market.
Dr Söhngen received her MD and PhD from RWTH Aachen University in Germany.
Proteome Sciences announced the appointment on 14 September 2020
Copyright 2020 Evernow Publishing Ltd